← Back to Search

Collaborative Care for Opioid Use Disorder

N/A

Waitlist Available

Led By Miriam Komaromy

Research Sponsored by RAND

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up asked about lifetime legal involvement; assessed at baseline and at 3 and 6 months

Awards & highlights

Study Summary

This trial will develop and test an intervention to reduce the risk of suicide and overdose among people with opioid use disorder and PTSD/depression.

Who is the study for?

This trial is for adults over 18 with opioid use disorder (OUD) and co-occurring mental health issues like depression or PTSD. Participants must be getting primary care at a participating site and able to consent. It's not for those under 18, non-English/Spanish speakers, or those treated outside the primary care system.Check my eligibility

What is being tested?

The study tests an enhanced collaborative care approach designed to lower suicide and overdose risks in individuals with OUD plus PTSD/depression. This builds on the parent CLARO study by adding more support for patients' complex needs.See study design

What are the potential side effects?

Since this trial focuses on a care approach rather than medication, side effects are not typical as with drug trials but may include discomfort from discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed over the previous 7 days at enrollment and at 3 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed over the previous 7 days at enrollment and at 3 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed over the previous 7 days at enrollment and at 3 and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

MOUD continuity of care

Secondary outcome measures

Opioid overdose risk behaviors

Suicide risk

Other outcome measures

Therapeutic procedure

Alcohol use severity

Clinician (care coordinator) communication

+12 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Collaborative Care PlusExperimental Treatment1 Intervention

Intervention is administered to patients in this arm. Care to be delivered via collaborative care. The supplement intervention adds family involvement in care and Caring Contacts, a suicide prevention method.

Group II: ControlActive Control1 Intervention

Patients in this arm will receive enhanced usual care.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Providence Saint John's Health CenterUNKNOWN

1 Previous Clinical Trials

900 Total Patients Enrolled

University of PittsburghOTHER

1,719 Previous Clinical Trials

16,342,041 Total Patients Enrolled

University of New MexicoOTHER

372 Previous Clinical Trials

3,528,489 Total Patients Enrolled

Media Library

Collaborative care Plus Clinical Trial Eligibility Overview. Trial Name: NCT04634279 — N/A

Opioid Use Disorder Research Study Groups: Collaborative Care Plus, Control

Opioid Use Disorder Clinical Trial 2023: Collaborative care Plus Highlights & Side Effects. Trial Name: NCT04634279 — N/A

Collaborative care Plus 2023 Treatment Timeline for Medical Study. Trial Name: NCT04634279 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor currently enrolling participants?

"According to clinicaltrials.gov, this research effort is currently recruiting volunteers; it was initially listed on August 31st 2022 and underwent its last edit on October 27th 2022."

Answered by AI

In what number of sites is this experiment accessible?

"Patients can consider enrollment at 18 different sites, such as Clinica Sierra Vista - Kern River Health Center in Wofford Heights, Hidalgo Medical Services - Lordsburg Clinic in Lordsburg, and Providence Saint John's Health Center in Santa Monica."

Answered by AI

What is the aggregate sum of participants in this research project?

"Indeed, the clinical trial is actively recruiting individuals. The original posting was made on August 31st 2022 and the details were recently modified on October 27th 2022. 300 participants from 18 sites are required to conclude this research project successfully."

Answered by AI